Company / Interest Expense per Share
Emergent BioSolutions Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.68
FY2023
5-year range
$0.67 / $1.68
FY2019-FY2023
Trend
+131.6%
vs FY2022
Sector context
#7 of 43
Health Care
What the data says
Emergent BioSolutions Inc.'s interest expense per share of $1.68 is higher than 84% of companies in the Health Care sector (FY2023). Interest Expense per Share has increased for 3 consecutive years, from $0.61 in FY2020 to $1.68 in FY2023.
Based on SEC 10-K filings.
1.68 in FY2023 with a 5-year CAGR of +61.4%. Top quartile in the Health Care sector.
Increased from $0.67 to $1.68 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +40.6%
- 5-Year CAGR
- +61.4%
- 10-Year CAGR
- -
Sector benchmark
-91.0% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s interest expense per share has grown for 3 consecutive years.
- In FY2023, interest expense per share increased 131.6% year-over-year.
- Ranks #7 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.68 | +131.6% |
| FY2022 | $0.73 | +8.1% |
| FY2021 | $0.67 | +11.1% |
| FY2020 | $0.61 | -18.5% |
| FY2019 | $0.74 | +382.8% |
| FY2018 | $0.15 | -5.4% |
| FY2017 | $0.16 | -15.7% |
| FY2016 | $0.19 | +11.5% |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026